Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28926115)

  • 1. Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis.
    Chang SM; Hu WW
    J Cell Physiol; 2018 Apr; 233(4):3384-3396. PubMed ID: 28926115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
    Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
    Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101.
    Li Z; Xu C; Ding B; Gao M; Wei X; Ji N
    J Neurooncol; 2017 Aug; 134(1):19-28. PubMed ID: 28551849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1.
    Han Y; Liu Y; Zhang H; Wang T; Diao R; Jiang Z; Gui Y; Cai Z
    FEBS Lett; 2013 Nov; 587(23):3875-82. PubMed ID: 24396870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer.
    Wang SH; Zhang WJ; Wu XC; Weng MZ; Zhang MD; Cai Q; Zhou D; Wang JD; Quan ZW
    J Cell Mol Med; 2016 Dec; 20(12):2299-2308. PubMed ID: 27420766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.
    Zhou X; Liu S; Cai G; Kong L; Zhang T; Ren Y; Wu Y; Mei M; Zhang L; Wang X
    Sci Rep; 2015 Nov; 5():15972. PubMed ID: 26522444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p.
    Liu K; Huang J; Ni J; Song D; Ding M; Wang J; Huang X; Li W
    Cell Cycle; 2017 Mar; 16(6):578-587. PubMed ID: 28346809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22.
    Luan W; Li L; Shi Y; Bu X; Xia Y; Wang J; Djangmah HS; Liu X; You Y; Xu B
    Oncotarget; 2016 Sep; 7(39):63901-63912. PubMed ID: 27564100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells.
    Liu S; Song L; Zeng S; Zhang L
    Tumour Biol; 2016 Jan; 37(1):633-40. PubMed ID: 26242259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development.
    Jin C; Yan B; Lu Q; Lin Y; Ma L
    Tumour Biol; 2016 Jun; 37(6):7383-94. PubMed ID: 26676637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
    Zuo Y; Li Y; Zhou Z; Ma M; Fu K
    Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA MALAT1 interacts with miR-124 and modulates tongue cancer growth by targeting JAG1.
    Zhang TH; Liang LZ; Liu XL; Wu JN; Su K; Chen JY; Zheng QY; Huang HZ; Liao GQ
    Oncol Rep; 2017 Apr; 37(4):2087-2094. PubMed ID: 28260102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long non-coding RNA MALAT1 promotes the migration and invasion of hepatocellular carcinoma by sponging miR-204 and releasing SIRT1.
    Hou Z; Xu X; Zhou L; Fu X; Tao S; Zhou J; Tan D; Liu S
    Tumour Biol; 2017 Jul; 39(7):1010428317718135. PubMed ID: 28720061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma.
    Xiao H; Tang K; Liu P; Chen K; Hu J; Zeng J; Xiao W; Yu G; Yao W; Zhou H; Li H; Pan Y; Li A; Ye Z; Wang J; Xu H; Huang Q
    Oncotarget; 2015 Nov; 6(35):38005-15. PubMed ID: 26461224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long intergenic non-coding RNA 668 regulates VEGFA signaling through inhibition of miR-297 in oral squamous cell carcinoma.
    Zhang CZ
    Biochem Biophys Res Commun; 2017 Aug; 489(4):404-412. PubMed ID: 28564590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p.
    Dong HX; Wang R; Jin XY; Zeng J; Pan J
    J Cell Physiol; 2018 May; 233(5):4126-4136. PubMed ID: 29030962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-Coding RNA MALAT1 Interacts With miR-204 to Modulate Human Hilar Cholangiocarcinoma Proliferation, Migration, and Invasion by Targeting CXCR4.
    Tan X; Huang Z; Li X
    J Cell Biochem; 2017 Nov; 118(11):3643-3653. PubMed ID: 28059437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA Malat1 promotes gallbladder cancer development by acting as a molecular sponge to regulate miR-206.
    Wang SH; Zhang WJ; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
    Oncotarget; 2016 Jun; 7(25):37857-37867. PubMed ID: 27191262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b.
    Tsang FH; Au SL; Wei L; Fan DN; Lee JM; Wong CC; Ng IO; Wong CM
    Liver Int; 2015 May; 35(5):1597-606. PubMed ID: 25424744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.